- Home
- JWEL vs NCNA Comparison
JWEL vs NCNA Comparison
Compare JWEL & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWEL
- NCNA
- Stock Information
- Founded
- JWEL 2012
- NCNA 1997
- Country
- JWEL China
- NCNA United Kingdom
- Employees
- JWEL N/A
- NCNA N/A
- Industry
- JWEL Other Consumer Services
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- JWEL Consumer Discretionary
- NCNA Health Care
- Exchange
- JWEL Nasdaq
- NCNA Nasdaq
- Market Cap
- JWEL 4.1M
- NCNA 4.5M
- IPO Year
- JWEL 2021
- NCNA 2017
- Fundamental
- Price
- JWEL $1.97
- NCNA $0.09
- Analyst Decision
- JWEL
- NCNA Buy
- Analyst Count
- JWEL 0
- NCNA 2
- Target Price
- JWEL N/A
- NCNA $25.00
- AVG Volume (30 Days)
- JWEL 3.5K
- NCNA 324.5M
- Earning Date
- JWEL 07-07-2025
- NCNA 08-14-2025
- Dividend Yield
- JWEL N/A
- NCNA N/A
- EPS Growth
- JWEL N/A
- NCNA N/A
- EPS
- JWEL N/A
- NCNA N/A
- Revenue
- JWEL $132,981,531.00
- NCNA N/A
- Revenue This Year
- JWEL N/A
- NCNA N/A
- Revenue Next Year
- JWEL N/A
- NCNA N/A
- P/E Ratio
- JWEL N/A
- NCNA N/A
- Revenue Growth
- JWEL N/A
- NCNA N/A
- 52 Week Low
- JWEL $1.18
- NCNA $0.03
- 52 Week High
- JWEL $3.71
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- JWEL 53.74
- NCNA 41.41
- Support Level
- JWEL $1.77
- NCNA $0.07
- Resistance Level
- JWEL $1.99
- NCNA $0.10
- Average True Range (ATR)
- JWEL 0.08
- NCNA 0.03
- MACD
- JWEL 0.00
- NCNA 0.01
- Stochastic Oscillator
- JWEL 63.64
- NCNA 25.70
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.